Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
NCT06027840Phase 1Completed
- Sponsor
- Yale University
- Start
- Apr 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of varenicline in nicotine dependence (2 arms), sponsored by Yale University. Primary endpoint: Cigarette Abstinence at Week 12- Carbon Monoxide. Started Apr 2024; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06027840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06027840.